|
1
|
Rossello X, Lobo-Gonzalez M and Ibanez B:
Editor's choice-pathophysiology and therapy of myocardial
ischaemia/reperfusion syndrome. Eur Heart J Acute Cardiovasc Care.
8:443–456. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hausenloy DJ and Yellon DM: Ischaemic
conditioning and reperfusion injury. Nat Rev Cardiol. 13:193–209.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu Y, Liu H and Wang X: Cardioprotection
of pharmacological postconditioning on myocardial
ischemia/reperfusion injury. Life Sci. 264(118628)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Xiong J, Yuan YJ, Xue FS, Wang Q, Cheng Y,
Li RP, Liao X and Liu JH: Postconditioning with α7nAChR agonist
attenuates systemic inflammatory response to myocardial
ischemia-reperfusion injury in rats. Inflammation. 35:1357–1364.
2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sack MN and Murphy E: The role of
comorbidities in cardioprotection. J Cardiovasc Pharmacol Ther.
16:267–272. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Andreadou I, Schulz R, Badimon L, Adameová
A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur
G, Woudberg N, et al: Hyperlipidaemia and cardioprotection: Animal
models for translational studies. Br J Pharmacol. 177:5287–5311.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bøtker HE: The future of
cardioprotection-pointing toward patients at elevated risk as the
target populations. J Cardiovasc Pharmacol Ther. 25:487–493.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Andreadou I, Iliodromitis EK, Lazou A,
Görbe A, Giricz Z, Schulz R and Ferdinandy P: Effect of
hypercholesterolaemia on myocardial function, ischaemia-reperfusion
injury and cardioprotection by preconditioning, postconditioning
and remote conditioning. Br J Pharmacol. 174:1555–1569.
2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
D'Annunzio V, Donato M, Buchholz B, Pérez
V, Miksztowicz V, Berg G and Gelpi RJ: High cholesterol diet
effects on ischemia-reperfusion injury of the heart. Can J Physiol
Pharmacol. 90:1185–1196. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ueda Y, Kitakaze M, Komamura K, Minamino
T, Asanuma H, Sato H, Kuzuya T, Takeda H and Hori M: Pravastatin
restored the infarct size-limiting effect of ischemic
preconditioning blunted by hypercholesterolemia in the rabbit model
of myocardial infarction. J Am Coll Cardiol. 34:2120–2125.
1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tang XL, Takano H, Xuan YT, Sato H, Kodani
E, Dawn B, Zhu Y, Shirk G, Wu WJ and Bolli R: Hypercholesterolemia
abrogates late preconditioning via a tetrahydrobiopterin-dependent
mechanism in conscious rabbits. Circulation. 112:2149–2156.
2005.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Iliodromitis EK, Zoga A, Vrettou A,
Andreadou I, Paraskevaidis IA, Kaklamanis L and Kremastinos DT: The
effectiveness of postconditioning and preconditioning on infarct
size in hypercholesterolemic and normal anesthetized rabbits.
Atherosclerosis. 188:356–362. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Jung O, Jung W, Malinski T, Wiemer G,
Schoelkens BA and Linz W: Ischemic preconditioning and infarct
mass: The effect of hypercholesterolemia and endothelial
dysfunction. Clin Exp Hypertens. 22:165–179. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang JT, Wang J, Zhou XR, Xiao C, Lou YY,
Tang LH, Zhang FJ and Qian LB: Luteolin alleviates cardiac
ischemia/reperfusion injury in the hypercholesterolemic rat via
activating Akt/Nrf2 signaling. Naunyn Schmiedebergs Arch Pharmacol.
391:719–728. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhang JQ, Wang Q, Xue FS, Li RP, Cheng Y,
Cui XL, Liao X and Meng FM: Ischemic preconditioning produces more
powerful anti-inflammatory and cardioprotective effects than limb
remote ischemic postconditioning in rats with myocardial
ischemia-reperfusion injury. Chin Med J (Engl). 126:3949–3955.
2013.PubMed/NCBI
|
|
16
|
Low LD, Lu L, Chan CY, Chen J, Yang HH, Yu
H, Lee CGL, Ng KH and Yap HK: IL-13-driven alterations in hepatic
cholesterol handling contributes to hypercholesterolemia in a rat
model of minimal change disease. Clin Sci (Lond). 134:225–237.
2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
He JY, Fan SX, Ma YL, Cao XF, Tian T and
Liu Y: Hypercholesterolemia abolishes the protective effect of
ischemic preconditioning on myocardial ischemia-reperfusion injury
in rats via PI3K/Akt pathway. Chin Rem Clin. 19:4024–4027.
2019.
|
|
18
|
Cui X, Wang S, Xue F, Yang G, Li H, Liu Y
and Liao X: Mechanism underlying inhibition of inflammatory
responses induced by α7nAChR agonist postconditioning alone or in
combination with remote limb ischemic postconditioning during
myocardial I/R in rats: The relationship with GSK-3β (Chinese).
Chin J Anesthesiol. 38:78–82. 2018.
|
|
19
|
Ungi I, Ungi T, Ruzsa Z, Nagy E,
Zimmermann Z, Csont T and Ferdinandy P: Hypercholesterolemia
attenuates the anti-ischemic effect of preconditioning during
coronary angioplasty. Chest. 128:1623–1628. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kocić I, Konstański Z, Kaminski M,
Dworakowska D and Dworakowski R: Experimental hyperlipidemia
prevents the protective effect of ischemic preconditioning on the
contractility and responsiveness to phenylephrine of rat-isolated
stunned papillary muscle. Gen Pharmacol. 33:213–219.
1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vincent A, Lattuca B, Merlet N,
Sportouch-Dukhan C and Barrère-Lemaire S: New insights in research
about acute ischemic myocardial injury and inflammation.
Antiinflamm Antiallergy Agents Med Chem. 12:47–54. 2013.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Steffens S, Montecucco F and Mach F: The
inflammatory response as a target to reduce myocardial ischaemia
and reperfusion injury. Thromb Haemost. 102:240–247.
2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rosenberg JH, Werner JH, Moulton MJ and
Agrawal DK: Current modalities and mechanisms underlying
cardioprotection by ischemic conditioning. J Cardiovasc Transl Res.
11:292–307. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hausenloy DJ and Yellon DM: Reperfusion
injury salvage kinase signalling: Taking a RISK for
cardioprotection. Heart Fail Rev. 12:217–234. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
He X, Zhao M, Bi XY, Yu XJ and Zang WJ:
Delayed preconditioning prevents ischemia/reperfusion-induced
endothelial injury in rats: Role of ROS and eNOS. Lab Invest.
93:168–180. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sun Y, Jiang C, Jiang J and Qiu L:
Dexmedetomidine protects mice against myocardium
ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS
pathway. Clin Exp Pharmacol Physiol. 44:946–953. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bai J, Wang Q, Qi J, Yu H, Wang C, Wang X,
Ren Y and Yang F: Promoting effect of baicalin on nitric oxide
production in CMECs via activating the PI3K-AKT-eNOS pathway
attenuates myocardial ischemia-reperfusion injury. Phytomedicine.
63(153035)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jones SP, Girod WG, Palazzo AJ, Granger
DN, Grisham MB, Jourd'Heuil D, Huang PL and Lefer DJ: Myocardial
ischemia-reperfusion injury is exacerbated in absence of
endothelial cell nitric oxide synthase. Am J Physiol.
276:H1567–H1573. 1999.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Shah DI and Singh M: Possible role of Akt
to improve vascular endothelial dysfunction in diabetic and
hyperhomocysteinemic rats. Mol Cell Biochem. 295:65–74.
2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Genda S, Miura T, Miki T, Ichikawa Y and
Shimamoto K: K(ATP) channel opening is an endogenous mechanism of
protection against the no-reflow phenomenon but its function is
compromised by hypercholesterolemia. J Am Coll Cardiol.
40:1339–1346. 2002.PubMed/NCBI View Article : Google Scholar
|
